Solventum Corporation (SOLV) Financials

SOLV Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 14.1 billion 9.1 billion
Dec. 31, 2025 14.3 billion 9.2 billion
Sept. 30, 2025 14.0 billion 9.0 billion
June 30, 2025 15.1 billion 11.4 billion

SOLV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -273.0 million 51.0 million
Dec. 31, 2025 32.0 million 37.0 million
Sept. 30, 2025 -21.0 million 41.0 million
June 30, 2025 59.0 million 34.0 million

SOLV Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 13.0 million
Dec. 31, 2025 63.0 million
Sept. 30, 2025 1.3 billion
June 30, 2025 90.0 million

SOLV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 561.0 million 4.6 billion 207.0 million
Dec. 31, 2025 878.0 million 5.0 billion -
Sept. 30, 2025 1.6 billion 5.1 billion -
June 30, 2025 492.0 million 7.8 billion -

SOLV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 175.5 million
Dec. 31, 2025 175.3 million
Sept. 30, 2025 175.4 million
June 30, 2025 175.2 million

SOLV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 84.0 million 189.0 million 827.0 million -
Dec. 31, 2025 63.0 million 176.0 million 759.0 million -
Sept. 30, 2025 97.0 million 183.0 million 780.0 million -
June 30, 2025 110.0 million 189.0 million 772.0 million -

SOLV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.0 billion 910.0 million
Dec. 31, 2025 2.0 billion 1.0 billion
Sept. 30, 2025 2.1 billion 919.0 million
June 30, 2025 2.2 billion 986.0 million

SOLV Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SOLV

Price: $78.60

52 week price:
62.38
88.20

Earnings Per Share: 8.17 USD

P/E Ratio: 9.58

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United Kingdom

Market Capitalization: 13.6 billion

Links: